186 related articles for article (PubMed ID: 24326777)
1. Optimized delivery system achieves enhanced endomyocardial stem cell retention.
Behfar A; Latere JP; Bartunek J; Homsy C; Daro D; Crespo-Diaz RJ; Stalboerger PG; Steenwinckel V; Seron A; Redfield MM; Terzic A
Circ Cardiovasc Interv; 2013 Dec; 6(6):710-8. PubMed ID: 24326777
[TBL] [Abstract][Full Text] [Related]
2. Improvement of Local Cell Delivery Using Helix Transendocardial Delivery Catheter in a Porcine Heart.
Mitsutake Y; Pyun WB; Rouy D; Foo CWP; Stertzer SH; Altman P; Ikeno F
Int Heart J; 2017 May; 58(3):435-440. PubMed ID: 28539564
[TBL] [Abstract][Full Text] [Related]
3. Advanced Material Catheter (AMCath), a minimally invasive endocardial catheter for the delivery of fast-gelling covalently cross-linked hyaluronic acid hydrogels.
Dolan EB; Kovarova L; O'Neill H; Pravda M; Sulakova R; Scigalkova I; Velebny V; Daro D; Braun N; Cooney GM; Bellavia G; Straino S; Cavanagh BL; Flanagan A; Kelly HM; Duffy GP; Murphy BP
J Biomater Appl; 2018 Nov; 33(5):681-692. PubMed ID: 30354912
[TBL] [Abstract][Full Text] [Related]
4. Widespread Myocardial Delivery of Heart-Derived Stem Cells by Nonocclusive Triple-Vessel Intracoronary Infusion in Porcine Ischemic Cardiomyopathy: Superior Attenuation of Adverse Remodeling Documented by Magnetic Resonance Imaging and Histology.
Tseliou E; Kanazawa H; Dawkins J; Gallet R; Kreke M; Smith R; Middleton R; Valle J; Marbán L; Kar S; Makkar R; Marbán E
PLoS One; 2016; 11(1):e0144523. PubMed ID: 26784932
[TBL] [Abstract][Full Text] [Related]
5. Incomplete retention after direct myocardial injection.
Grossman PM; Han Z; Palasis M; Barry JJ; Lederman RJ
Catheter Cardiovasc Interv; 2002 Mar; 55(3):392-7. PubMed ID: 11870950
[TBL] [Abstract][Full Text] [Related]
6. Assessment of safety, accuracy, and human CD34+ cell retention after intramyocardial injections with a helical needle catheter in a porcine model.
Kumar A; Haralampus CA; Hughes M; Rouy D; Cresswell N; Braun R; Turner D; Amrani D; Motlagh D; Schaer GL
Catheter Cardiovasc Interv; 2013 May; 81(6):970-7. PubMed ID: 22581763
[TBL] [Abstract][Full Text] [Related]
7. Development of a transplant injection device for optimal distribution and retention of human induced pluripotent stem cell‒derived cardiomyocytes.
Tabei R; Kawaguchi S; Kanazawa H; Tohyama S; Hirano A; Handa N; Hishikawa S; Teratani T; Kunita S; Fukuda J; Mugishima Y; Suzuki T; Nakajima K; Seki T; Kishino Y; Okada M; Yamazaki M; Okamoto K; Shimizu H; Kobayashi E; Tabata Y; Fujita J; Fukuda K
J Heart Lung Transplant; 2019 Feb; 38(2):203-214. PubMed ID: 30691596
[TBL] [Abstract][Full Text] [Related]
8. Epicardial delivery of VEGF and cardiac stem cells guided by 3-dimensional PLLA mat enhancing cardiac regeneration and angiogenesis in acute myocardial infarction.
Chung HJ; Kim JT; Kim HJ; Kyung HW; Katila P; Lee JH; Yang TH; Yang YI; Lee SJ
J Control Release; 2015 May; 205():218-30. PubMed ID: 25681051
[TBL] [Abstract][Full Text] [Related]
9. Chitosan/silk fibroin modified nanofibrous patches with mesenchymal stem cells prevent heart remodeling post-myocardial infarction in rats.
Chen J; Zhan Y; Wang Y; Han D; Tao B; Luo Z; Ma S; Wang Q; Li X; Fan L; Li C; Deng H; Cao F
Acta Biomater; 2018 Oct; 80():154-168. PubMed ID: 30218777
[TBL] [Abstract][Full Text] [Related]
10. Magnetic resonance fluoroscopy allows targeted delivery of mesenchymal stem cells to infarct borders in Swine.
Dick AJ; Guttman MA; Raman VK; Peters DC; Pessanha BS; Hill JM; Smith S; Scott G; McVeigh ER; Lederman RJ
Circulation; 2003 Dec; 108(23):2899-904. PubMed ID: 14656911
[TBL] [Abstract][Full Text] [Related]
11. Intracoronary and retrograde coronary venous myocardial delivery of adipose-derived stem cells in swine infarction lead to transient myocardial trapping with predominant pulmonary redistribution.
Hong SJ; Hou D; Brinton TJ; Johnstone B; Feng D; Rogers P; Fearon WF; Yock P; March KL
Catheter Cardiovasc Interv; 2014 Jan; 83(1):E17-25. PubMed ID: 22972685
[TBL] [Abstract][Full Text] [Related]
12. Cell distribution after intracoronary bone marrow stem cell delivery in damaged and undamaged myocardium: implications for clinical trials.
Forest VF; Tirouvanziam AM; Perigaud C; Fernandes S; Fusellier MS; Desfontis JC; Toquet CS; Heymann MF; Crochet DP; Lemarchand PF
Stem Cell Res Ther; 2010 Mar; 1(1):4. PubMed ID: 20504285
[TBL] [Abstract][Full Text] [Related]
13. The use of micro-needle arrays to deliver cells for cellular therapies.
Chen YH; Lin DC; Chern E; Huang YY
Biomed Microdevices; 2020 Sep; 22(4):63. PubMed ID: 32889555
[TBL] [Abstract][Full Text] [Related]
14. Cyclin D2 Overexpression Enhances the Efficacy of Human Induced Pluripotent Stem Cell-Derived Cardiomyocytes for Myocardial Repair in a Swine Model of Myocardial Infarction.
Zhao M; Nakada Y; Wei Y; Bian W; Chu Y; Borovjagin AV; Xie M; Zhu W; Nguyen T; Zhou Y; Serpooshan V; Walcott GP; Zhang J
Circulation; 2021 Jul; 144(3):210-228. PubMed ID: 33951921
[TBL] [Abstract][Full Text] [Related]
15. Non-invasive in vivo imaging of cardiac stem/progenitor cell biodistribution and retention after intracoronary and intramyocardial delivery in a swine model of chronic ischemia reperfusion injury.
Collantes M; Pelacho B; García-Velloso MJ; Gavira JJ; Abizanda G; Palacios I; Rodriguez-Borlado L; Álvarez V; Prieto E; Ecay M; Larequi E; Peñuelas I; Prósper F
J Transl Med; 2017 Mar; 15(1):56. PubMed ID: 28288654
[TBL] [Abstract][Full Text] [Related]
16. Externally Applied Static Magnetic Field Enhances Cardiac Retention and Functional Benefit of Magnetically Iron-Labeled Adipose-Derived Stem Cells in Infarcted Hearts.
Wang J; Xiang B; Deng J; Lin HY; Zheng D; Freed DH; Arora RC; Tian G
Stem Cells Transl Med; 2016 Oct; 5(10):1380-1393. PubMed ID: 27400797
[TBL] [Abstract][Full Text] [Related]
17. In Situ Preconditioning of Human Mesenchymal Stem Cells Elicits Comprehensive Cardiac Repair Following Myocardial Infarction.
Sim WS; Park BW; Ban K; Park HJ
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535594
[TBL] [Abstract][Full Text] [Related]
18. Pericardial application as a new route for implanting stem-cell cardiospheres to treat myocardial infarction.
Zhang J; Wu Z; Fan Z; Qin Z; Wang Y; Chen J; Wu M; Chen Y; Wu C; Wang J
J Physiol; 2018 Jun; 596(11):2037-2054. PubMed ID: 29736937
[TBL] [Abstract][Full Text] [Related]
19. Combinatorial treatment of acute myocardial infarction using stem cells and their derived exosomes resulted in improved heart performance.
Huang P; Wang L; Li Q; Xu J; Xu J; Xiong Y; Chen G; Qian H; Jin C; Yu Y; Liu J; Qian L; Yang Y
Stem Cell Res Ther; 2019 Oct; 10(1):300. PubMed ID: 31601262
[TBL] [Abstract][Full Text] [Related]
20. A comparison of the efficacy of transplantation of bone marrow-derived mesenchymal stem cells and unrestricted somatic stem cells on outcome after acute myocardial infarction.
Flynn A; Chen X; O'Connell E; O'Brien T
Stem Cell Res Ther; 2012 Sep; 3(5):36. PubMed ID: 22974654
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
